Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
7781 - 7790 of 9036 Results
Title
Year
  • Year
  • 2023
  • 2012
  • 2018
  • 2013
  • 2015
  • 2015
  • 2017
  • 2017
  • 2018
  • 2018
  • Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
    2023
    Summary Details
    OPEN
    Title: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications
    Author(s): Riham Ayoubi, Joël Ryan, Michael Biddle, Walaa Alshafie, Maryam Fotouhi, Sara González Bolívar, Vera Ruíz Moleón, Peter Eckmann, Donovan Worrall, Ian McDowell, Kathleen Southern, Wolfgang Reintsch, Thomas M. Durcan, Claire M. Brown, Anita Bandrowski, Harvinder Virk, A.M. Edwards, Peter S. McPherson, Carl Laflamme
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Vol: 12
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.91645.2
    Best OA location URL: https://doi.org/10.7554/elife.91645.2
    Citation Count: 46
  • Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s Disease
    2012
    Summary Details
    OPEN
    Title: Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s Disease
    Author(s): Melissa M. Amick, Ivy N. Miller, Sandy Neargarder, Alice Cronin‐Golomb
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Vol: 2012
    Issue #:
    Start Page: 1
    End Page: 7
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2012/564812
    Best OA location URL: https://downloads.hindawi.com/journals/pd/2012/564812.pdf
    Citation Count: 4
  • Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD
    2018
    Summary Details
    RESTRICTED
    Title: Long-term effect of low frequency stimulation of STN on dysphagia, freezing of gait and other motor symptoms in PD
    Author(s): Tao Xie, Lisa Bloom, Mahesh Padmanaban, Breanna Bertacchi, Wenjun Kang, Ellen MacCracken, Abraham H. Dachman, Julie Vigil, David Satzer, Cindy Zadikoff, Katerina Markopoulou, Peter C. Warnke, Un Jung Kang
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Vol: 89
    Issue #: 9
    Start Page: 989
    End Page: 994
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1136/jnnp-2018-318060
    Citation Count: 80
  • Which dyskinesia scale best detects treatment response?
    2013
    Summary Details
    RESTRICTED
    Title: Which dyskinesia scale best detects treatment response?
    Author(s): Christopher G. Goetz, Glenn T. Stebbins, Kathryn A. Chung, Robert A. Hauser, Janis M. Miyasaki, Anthony P. Nicholas, Werner Poewe, Klaus Seppi, Olivier Rascol, Mark Stacy, John G. Nutt, Caroline M. Tanner, Alison Urkowitz, Jean A. Jaglin, Ge Song
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 28
    Issue #: 3
    Start Page: 341
    End Page: 346
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25321
    Citation Count: 89
  • Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the Brain
    2015
    Summary Details
    OPEN
    Title: Rationally Designed MicroRNA-Based Genetic Classifiers Target Specific Neurons in the Brain
    Author(s): Marianna Sayeg, Benjamin H. Weinberg, S. Susie, Michael Goodloe, Wilson W. Wong, Xue Han
    Journal Name: ACS Synthetic Biology
    Publisher: American Chemical Society (ACS)
    Vol: 4
    Issue #: 7
    Start Page: 788
    End Page: 795
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acssynbio.5b00040
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4547530
    Citation Count: 32
  • The Discovery of Central Nervous System Lymphatic Vessels: The Missing Link That Closes the Circle of Brain Immunosurveillance
    2015
    Summary Details
    OPEN
    Title: The Discovery of Central Nervous System Lymphatic Vessels: The Missing Link That Closes the Circle of Brain Immunosurveillance
    Author(s): Bettina Balint, María Stamelou
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Vol: 3
    Issue #: 1
    Start Page: 29
    End Page: 30
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12282
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12282
    Citation Count: 1
  • Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
    2017
    Summary Details
    OPEN
    Title: Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
    Author(s): Ludovico Arcuri, Salvatore Novello, Martina Frassineti, Daniela Mercatelli, Clarissa Anna Pisanò, Ilaria Morella, Stefania Fasano, V. Blair Journigan, Michael E. Meyer, Willma E. Polgar, Riccardo Brambilla, Nurulain T. Zaveri, Michele Morari
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Vol: 175
    Issue #: 5
    Start Page: 782
    End Page: 796
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.14123
    Best OA location URL: https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14123
    Citation Count: 22
  • Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study
    2017
    Summary Details
    RESTRICTED
    Title: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study
    Author(s): Christopher G. Goetz, Glenn T. Stebbins, Kathryn A. Chung, Anthony P. Nicholas, Robert A. Hauser, Douglas Merkitch, Mark Stacy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 32
    Issue #: 9
    Start Page: 1335
    End Page: 1336
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27092
    Citation Count: 13
  • Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies Treatment
    2018
    Summary Details
    OPEN
    Title: Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies Treatment
    Author(s): Thomas Foltynie, Dilan Athauda
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Vol: 5
    Issue #: 3
    Start Page: 255
    End Page: 258
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12611
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12611
    Citation Count: 7
  • Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease
    2018
    Summary Details
    RESTRICTED
    Title: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease
    Author(s): Amirah E.-E. Aly, Brendan Harmon, Linas Padegimas, Ozge Sesenoglu‐Laird, Mark J. Cooper, Barbara L. Waszczak
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Vol: 56
    Issue #: 1
    Start Page: 688
    End Page: 701
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6
    Citation Count: 66
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.